Related references
Note: Only part of the references are listed.Dual-targeting Approach on Histamine H3 and Sigma-1 Receptor Ligands as Promising Pharmacological Tools in the Treatment of CNS-linked Disorders
Katarzyna Szczepanska et al.
CURRENT MEDICINAL CHEMISTRY (2021)
Novel compounds with dual S1P receptor agonist and histamine H3 receptor antaglonist activities act protective in a mouse model of multiple sclerosis
Faik Imeri et al.
NEUROPHARMACOLOGY (2021)
Sigma-1 receptor: A drug target for the modulation of neuroimmune and neuroglial interactions during chronic pain
M. Carmen Ruiz-Cantero et al.
PHARMACOLOGICAL RESEARCH (2021)
Structural modifications in the distal, regulatory region of histamine H3 receptor antagonists leading to the identification of a potent anti-obesity agent
Katarzyna Szczepanska et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
A Versatile Sub-Nanomolar Fluorescent Ligand Enables NanoBRET Binding Studies and Single-Molecule Microscopy at the Histamine H3 Receptor
Niklas Rosier et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Repurposing of FDA-Approved Drugs for Treating Iatrogenic Botulism: A Paired 3D-QSAR/Docking Approach†
Giuseppe Floresta et al.
CHEMMEDCHEM (2020)
UR-DEBa242: A Py-5-Labeled Fluorescent Multipurpose Probe for Investigations on the Histamine H3 and H4 Receptors
Edith Bartole et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Sigma Receptor Ligands Carrying a Nitric Oxide Donor Nitrate Moiety: Synthesis, In Silico, and Biological Evaluation
Emanuele Amata et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Putative Inhibitors of SARS-CoV-2 Main Protease from A Library of Marine Natural Products: A Virtual Screening and Molecular Modeling Study
Davide Gentile et al.
MARINE DRUGS (2020)
Epigenetics meets GPCR: inhibition of histone H3 methyltransferase (G9a) and histamine H3 receptor for Prader-Willi Syndrome
David Reiner et al.
SCIENTIFIC REPORTS (2020)
New Anti SARS-Cov-2 Targets for Quinoline Derivatives Chloroquine and Hydroxychloroquine
Davide Gentile et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Rational design of new multitarget histamine H3 receptor ligands as potential candidates for treatment of Alzheimer's disease
Dorota Lazewska et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
N-Substituted piperazine derivatives as potential multitarget agents acting on histamine H3 receptor and cancer resistance proteins
Katarzyna Szczepanska et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
A Dynamic, Split-Luciferase-Based Mini-G Protein Sensor to Functionally Characterize Ligands at All Four Histamine Receptor Subtypes
Carina Horing et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Polypharmacology by Design: A Medicinal Chemist's Perspective on Multitargeting Compounds
Ewgenij Proschak et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Morphing of Ibogaine: A Successful Attempt into the Search for Sigma-2 Receptor Ligands
Giuseppe Floresta et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Histamine H3 receptor antagonists/inverse agonists: Where do they go?
Nakisa Ghamari et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Search for multifunctional agents against Alzheimer's disease among non-imidazole histamine H3 receptor ligands. In vitro and in vivo pharmacological evaluation and computational studies of piperazine derivatives
Jakub Jonczyk et al.
BIOORGANIC CHEMISTRY (2019)
Structural modifications and in vitro pharmacological evaluation of 4-pyridyl-piperazine derivatives as an active and selective histamine H3 receptor ligands
Katarzyna Szczepanska et al.
BIOORGANIC CHEMISTRY (2019)
Computational Tools in the Discovery of FABP4 Ligands: A Statistical and Molecular Modeling Approach
Giuseppe Floresta et al.
MARINE DRUGS (2019)
Drug-receptor kinetics and sigma-1 receptor affinity differentiate clinically evaluated histamine H3 receptor antagonists
Darren M. Riddy et al.
NEUROPHARMACOLOGY (2019)
(+)-Methyl (1R,2S)-2-{[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]methyl}-1-phenylcyclopropanecarboxylate [(+)-MR200] Derivatives as Potent and Selective Sigma Receptor Ligands: Stereochemistry and Pharmacological Properties
Emanuele Amata et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Alzheimer's Disease, the One-Molecule, One-Target Paradigm, and the Multitarget Directed Ligand Approach
Maria Jesus Oset-Gasque et al.
ACS CHEMICAL NEUROSCIENCE (2018)
Synthesis and biological activity of novel tert-butyl and tert-pentylphenoxyalkyl piperazine derivatives as histamine H3R ligands
Katarzyna Szczepanska et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Benzomorphan skeleton, a versatile scaffold for different targets: A comprehensive review
Rita Turnaturi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Novel Sigma-1 receptor antagonists: from opioids to small molecules: what is new?
Emanuela Arena et al.
FUTURE MEDICINAL CHEMISTRY (2018)
Contilisant, a Tetratarget Small Molecule for Alzheimer's Disease Therapy Combining Cholinesterase, Monoamine Oxidase Inhibition, and H3R Antagonism with S1R Agonism Profile
Oscar M. Bautista-Aguilera et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Modality-specific peripheral antinociceptive effects of μ-opioid agonists on heat and mechanical stimuli: Contribution of sigma-1 receptors
Angeles Montilla-Garcia et al.
NEUROPHARMACOLOGY (2018)
Optimization and preclinical evaluation of novel histamine H-3 receptor ligands: Acetyl and propionyl phenoxyalkyl piperazine derivatives
Katarzyna Szczepanska et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
A Structure- and Ligand-Based Virtual Screening of a Database of Small Marine Natural Products for the Identification of Blue Sigma-2 Receptor Ligands
Giuseppe Floresta et al.
MARINE DRUGS (2018)
(+)-and (-)-Phenazocine enantiomers: Evaluation of their dual opioid agonist/σ1 antagonist properties and antinociceptive effects
O. Prezzavento et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Novel Sigma Receptor Ligand-Nitric Oxide Photodonors: Molecular Hybrids for Double-Targeted Antiproliferative Effect
Emanuele Amata et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
The proof-of-concept of ASS234: Peripherally administered ASS234 enters the central nervous system and reduces pathology in a male mouse model of Alzheimer disease
Mari Paz Serrano et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2017)
Multitarget-Directed Ligands Combining Cholinesterase and Monoamine Oxidase Inhibition with Histamine H3R Antagonism for Neurodegenerative Diseases
Oscar M. Bautista-Aguilera et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Sigma 2 Receptor/Tmem97 Agonists Produce Long Lasting Antineuropathic Pain Effects in Mice
James J. Sahn et al.
ACS CHEMICAL NEUROSCIENCE (2017)
NanoLuc Complementation Reporter Optimized for Accurate Measurement of Protein Interactions in Cells
Andrew S. Dixon et al.
ACS CHEMICAL BIOLOGY (2016)
The dual-acting AChE inhibitor and H3 receptor antagonist UW-MD-72 reverses amnesia induced by scopolamine or dizocilpine in passive avoidance paradigm in rats
Bassem Sadek et al.
PHYSIOLOGY & BEHAVIOR (2016)
Characterization of Three Novel Fatty Acid- and Retinoid-Binding Protein Genes (Ha-far-1, Ha-far-2 and Hf-far-1) from the Cereal Cyst Nematodes Heterodera avenae and H. filipjevi
Fen Qiao et al.
PLOS ONE (2016)
Polypharmacology in Precision Oncology: Current Applications and Future Prospects
Albert A. Antolin et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
The effects of sigma (σ1) receptor-selective ligands on muscarinic receptor antagonist-induced cognitive deficits in mice
Maninder Malik et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Sigma-1 receptor and inflammatory pain
Georgia Gris et al.
INFLAMMATION RESEARCH (2015)
Sigma-1 receptor: The novel intracellular target of neuropsychotherapeutic drugs
Teruo Hayashi
JOURNAL OF PHARMACOLOGICAL SCIENCES (2015)
[3H]UR-DE257: Development of a Tritium-Labeled Squaramide-Type Selective Histamine H2 Receptor Antagonist
Paul Baumeister et al.
CHEMMEDCHEM (2015)
Synthesis, Biological Evaluation, and Computational Studies of Tri- and Tetracyclic Nitrogen-Bridgehead Compounds as Potent Dual-Acting AChE Inhibitors and hH3 Receptor Antagonists
Fouad H. Darras et al.
ACS CHEMICAL NEUROSCIENCE (2014)
Selective sigma-1 receptor antagonists for the treatment of pain
Carmen Almansa et al.
FUTURE MEDICINAL CHEMISTRY (2014)
Modulation of Peripheral mu-Opioid Analgesia by sigma(1) Receptors
Cristina Sanchez-Fernandez et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Sigma 1 receptor: A new therapeutic target for pain
Daniel Zamanillo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Lessons Learned in Empirical Scoring with smina from the CSAR 2011 Benchmarking Exercise
David Ryan Koes et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2013)
Potentiation of morphine-induced mechanical antinociception by σ1 receptor inhibition: Role of peripheral σ1 receptors
Cristina Sanchez-Fernandez et al.
NEUROPHARMACOLOGY (2013)
Fused bicyclic heteroarylpiperazine- substituted L-prolylthiazolidines as highly potent DPP-4 inhibitors lacking the electrophilic nitrile group
Tomohiro Yoshida et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Histamine H3 Receptor as a Drug Discovery Target
Michael Berlin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Dual-Acting Drugs: an in vitro Study of Nonimidazole Histamine H3 Receptor Antagonists Combining Anticholinesterase Activity
Matteo Incerti et al.
CHEMMEDCHEM (2010)
Sigma-1 ligands: Tic-hydantoin as a key pharmacophore
Marion Toussaint et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Software News and Update AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading
Oleg Trott et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2010)
Histamine in the CNS Multiple functions and potential neurologic implications
Eduardo E. Benarroch
NEUROLOGY (2010)
Direct involvement of σ-1 receptors in the dopamine D1 receptor-mediated effects of cocaine
Gemma Navarro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
N-Benzyl-indolo carboxylic acids: Design and synthesis of potent and selective adipocyte fatty-acid binding protein (A-FABP) inhibitors
Tjeerd Barf et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Tritium-Labeled N1-[3-(1H-imidazol-4-yl)propyl]-N2-propionylguanidine ([3H]UR-PI294), a High-Affinity Histamine H3 and H4 Receptor Radioligand
Patrick Igel et al.
CHEMMEDCHEM (2009)
The histamine H3 receptor as a therapeutic drug target for CNS disorders
Mark J. Gemkow et al.
DRUG DISCOVERY TODAY (2009)
Possible involvement of sigma-1 receptors in the anti-immobility action of bupropion, a dopamine reuptake inhibitor
Ashish Dhir et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2008)
Multi-target-directed ligands to combat neurodegenerative diseases
Andrea Cavalli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
The Thermodynamics of Protein-Ligand Interaction and Solvation: Insights for Ligand Design
Tjelvar S. G. Olsson et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Sigma-1 receptor chaperones at the ER-Mitochondrion interface regulate Ca2+ signaling and cell survival
Teruo Hayashi et al.
CELL (2007)
Fluorine-18-labeled benzamide analogues for imaging the σ2 receptor status of solid tumors with positron emission tomography
Zhude Tu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Multi-target therapeutics: when the whole is greater than the sum of the parts
Grant R. Zimmermann et al.
DRUG DISCOVERY TODAY (2007)
Pharmacophore identification for sigma-1 (σ1) receptor binding:: Application of the deconstruction reconstruction elaboration approach
RA Glennon
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2005)
Multicomponent therapeutics for networked systems
CT Keith et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Optimization of parameters for semiempirical methods IV: extension of MNDO, AM1, and PM3 to more main group elements
JJP Stewart
JOURNAL OF MOLECULAR MODELING (2004)
Is a nitrogen atom an important pharmacophoric element in sigma ligand binding?
SY Ablordeppey et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2000)
Share Paper
